Credit: Shutterstock photoMerrimack Pharmaceuticals, Inc. ( MACK ) will begin trading ex-dividend on May 30, 2017. A cash dividend payment of $1.06 per share is scheduled to be paid on May 26, 2017. Shareholders who purchased MACK prior to the ex-dividend date are eligible for the cash dividend payment. At the current stock price of $3.41, the dividend yield is 123.78%.
The previous trading day's last sale of MACK was $3.41, representing a -52.24% decrease from the 52 week high of $7.14 and a 20.49% increase over the 52 week low of $2.83.
MACK is a part of the Health Care sector, which includes companies such as Johnson & Johnson ( JNJ ) and Novartis AG ( NVS ). MACK's current earnings per share, an indicator of a company's profitability, is -$1.11. Zacks Investment Research reports MACK's forecasted earnings growth in 2017 as 55.65%, compared to an industry average of 7.2%.
For more information on the declaration, record and payment dates, visit the MACK Dividend History page. Our Dividend Calendar has the full list of stocks that have an ex-dividend today.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
